NAPSA Antikörper (AA 64-420)
Kurzübersicht für NAPSA Antikörper (AA 64-420) (ABIN7161043)
Target
Alle NAPSA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 64-420
-
Kreuzreaktivität
- Human, Maus
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Napsin-A protein (64-420AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Andere Bezeichnung
- NAPSA
-
Hintergrund
-
Background: May be involved in processing of pneumocyte surfactant precursors.
Aliases: Asp 4 antibody, ASP4 antibody, Aspartyl protease 4 antibody, KAP antibody, Kdap antibody, Kidney derived aspartic protease like protein antibody, NAP1 antibody, NAPA antibody, Napsa antibody, NAPSA_HUMAN antibody, Napsin 1 antibody, napsin A aspartic peptidase antibody, Napsin A precursor antibody, Napsin-1 antibody, Napsin-A antibody, Pronapsin A antibody, SNAPA antibody, TA01/TA02 antibody
-
UniProt
- O96009
-
Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Target
-